Exploring the relationship between Endothelin-1 and peripheral inflammation in multiple sclerosis.

Area of Science:

• Neuroimmunology
• Vascular Biology

Background:

• Neuroinflammation and neurodegeneration are key in multiple sclerosis (MS) progression.
• Endothelin-1 (ET-1) is implicated in MS-related hypoperfusion and tissue damage.
• The link between ET-1 and neuroinflammation in MS is not well understood.

Purpose of the Study:

• To measure plasma ET-1 levels in treatment-naïve MS patients and controls.
• To investigate the relationship between ET-1 and peripheral immune mediators in MS.
• To identify potential biomarkers for MS disease processes.

Main Methods:

• Retrospective analysis of samples from 35 treatment-naïve MS patients and 35 controls.
• Quantification of plasma ET-1 using ELISA.
• Simultaneous measurement of 10 plasma cytokines (ILs and IFNs) using Multiplex assay.

Main Results:

• MS patients showed significantly higher plasma ET-1 levels than controls.
• No significant differences in overall cytokine levels were observed between groups.
• An increased IFN-γ/IL-4 ratio indicated a Th1-skewed immune response in MS patients.
• ET-1, IL-4, and IFN-γ were identified as independent predictors of MS diagnosis.

Conclusions:

• MS patients exhibit elevated ET-1 and a Th1-biased immune profile.
• ET-1 and Th1 cytokine profiles are independent predictors of MS.
• ET-1 levels in MS do not correlate with peripheral immune markers, suggesting independent pathways.